MD Anderson Cancer Centerr
Welcome,         Profile    Billing    Logout  
 11 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yennu, Sriram
NCI-2018-00698, NCT03525873: Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy

Active, not recruiting
3
212
US
Laboratory Biomarker Analysis, Methylphenidate, Daytrana, Physical Activity, Placebo, placebo therapy, PLCB, sham therapy, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm
12/24
12/24
NCT02491632: Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Active, not recruiting
2/3
90
US
Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, Visumetazone, Exercise Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Advanced Malignant Neoplasm, Fatigue, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant Neoplasm
03/19
12/26
NCI-2019-01027, NCT03927885: Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

Active, not recruiting
2/3
100
US
Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Waiting List, Waitlist
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm
12/26
12/26
NCI-2018-01103, NCT03583255: Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer

Active, not recruiting
2/3
99
US
Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Exercise Intervention, Placebo Administration
M.D. Anderson Cancer Center, National Institute of Nursing Research (NINR)
Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm
12/25
12/25
NCI-2018-01593, NCT03637816: Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Active, not recruiting
2/3
25
US
Anamorelin Hydrochloride, RC-1291 HCl, Placebo, placebo therapy, PLCB, sham therapy, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
12/24
12/24
NCI-2018-02527, NCT03772834: Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

Recruiting
2/3
200
US
Exercise Intervention, Methylphenidate, Daytrana, Placebo, placebo therapy, PLCB, sham therapy, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Stretching
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Prostate Carcinoma
11/26
11/26
NCT05474846: Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Recruiting
2/3
188
US
Melatonin, Methylphenidate Given by PO, Behavioral: Bright Light Therapy, Behavioral: Cognitive Behavior Therapy, Placebo for Melatonin, Placebo for Methylphendate Given by PO, Control Light Therapy Sham Therapy, behavioral: Cognitive Behavior Therapy Counseling session, Placebo for Methylphenidate Given by PO, Behavioral: Bright Light Therapy Given by PO, Behavioral: Cognitive Behavior Therapy Counseling session, Methylphenidate, Placebo for Melatonin Given by PO
M.D. Anderson Cancer Center
Sleep, Fatigue, Anxiety, Cancer, Depression
02/27
02/27
NCT06085716: Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

Recruiting
2/3
240
US
Psychoeducational Intervention, Open Label Placebo, Psychoeducational Intervention+Placebo
M.D. Anderson Cancer Center
Metastatic Cancers, Fatigue
08/27
08/29
NCT03035409: Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

Active, not recruiting
2
129
US
Anamorelin Hydrochloride, RC-1291 HCl, Exercise Intervention, Laboratory Biomarker Analysis, Nutritional Assessment, Dietary Assessment, dietary counseling, nutritional counseling, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm, C-Reactive Protein Measurement, Cancer Fatigue, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Weight Loss
12/19
02/26
NCT05077072: Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients

Recruiting
2
72
US
Best Practice, standard of care, standard therapy, Counseling, Counseling Intervention, Electroencephalography, EEG, electroencephalogram, Neurofeedback, EEG biofeedback, Questionnaire Administration
M.D. Anderson Cancer Center
Head and Neck Carcinoma
06/24
06/24
NCT03747757: Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

Active, not recruiting
2
48
US
Cognitive Behavior Therapy, CBT, cognitive therapy, CT, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue, Lymphoma, Secondary Acute Myeloid Leukemia
09/25
09/25
NCT01628029: Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Active, not recruiting
2
68
US
Counseling, Counseling Intervention, Methylphenidate Hydrochloride, Concerta, Quillivant XR, Ritalin, Phototherapy, Actinotherapy, Bright Light Therapy, light therapy, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Sham Intervention, Sham Comparator, Therapeutic Melatonin, Circadin, Melatonin, Melaxen
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder
12/25
12/25
NCT04984551: Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Recruiting
N/A
312
US
Extension of Community Health (ECHO) Telementoring Clinic, In-Country Workshops, Professional Oncology Educations Programs, Medical Chart Review, Chart Review, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm
12/26
12/26
NCT05634551: Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status

Active, not recruiting
N/A
110
US
Questionnaires, Interview
M.D. Anderson Cancer Center, Conquer Cancer Foundation
Non-small Cell Lung Cancer
12/25
12/25
NCT05044312: Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

Not yet recruiting
N/A
200
US
Sleeping Disturbances
M.D. Anderson Cancer Center, American Cancer Society, Inc.
GI Cancers, Gastrointestinal Cancer
12/26
12/26

Download Options